COVID-19
16 Sep 2021
Glenmark concludes PMS study on Favipiravir in 1000+ COVID-19 patients
Findings reinforce drug's safety and efficacy in real-world settings Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, announced the successful…
